PART I AEON is a biopharmaceutical company advancing its proprietary botulinum toxin complex ABP-450 as a biosimilar to Botox (onabotulinumtoxinA) with the goal of achieving full-label United States (U.S.) market entry for debilitating medical conditions. On December 12, 2022, AEON Biopharma Sub, Inc. (formerly known as AEON Biopharma, Inc.) (Old AEON) and Priveterra Merger Sub, Inc., a wholly owned subsidiary of Priveterra Acquisition Corp. (Priveterra), a special purpose acquisition company fo...
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001837607-26-000019 | EDGAR | 96K words |
| 2025-03-24 | 2024-12-31 | 0001837607-25-000022 | EDGAR | — |
| 2024-03-29 | 2023-12-31 | 0001837607-24-000015 | EDGAR | — |
| 2023-02-22 | 2022-12-31 | 0001104659-23-023947 | EDGAR | — |
| 2022-03-28 | 2021-12-31 | 0001104659-22-038759 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001104659-21-044781 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001837607-25-000085 | EDGAR | 31K words |
| 2025-08-12 | 2025-06-30 | 0001837607-25-000066 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001837607-25-000050 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001837607-24-000093 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0001558370-24-011896 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001837607-24-000063 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001558370-23-018706 | EDGAR | — |
| 2023-07-21 | 2023-06-30 | 0001104659-23-082959 | EDGAR | — |
| 2023-05-17 | 2023-03-31 | 0001104659-23-061821 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001104659-22-117341 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001104659-22-090142 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001104659-22-059538 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-03 | 0001837607-26-000025 | EDGAR | 1K words |
| 2026-03-30 | 0001837607-26-000018 | EDGAR | — |
| 2026-03-09 | 0001837607-26-000009 | EDGAR | — |
| 2026-01-21 | 0001837607-26-000005 | EDGAR | — |
| 2026-01-12 | 0001837607-26-000002 | EDGAR | — |
| 2025-12-15 | 0001837607-25-000092 | EDGAR | — |
| 2025-12-04 | 0001837607-25-000088 | EDGAR | — |
| 2025-11-14 | 0001837607-25-000084 | EDGAR | — |
| 2025-11-13 | 0001837607-25-000072 | EDGAR | — |
| 2025-09-08 | 0001837607-25-000068 | EDGAR | — |
130 total filings indexed. 102 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001837607 |
| Ticker | AEON |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.aeonbiopharma.com |
| Listed | 2023-07-24 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report